Parkinson's disease treatment may cause impulse–control disorder via dopamine D3 receptors

E-ISSN： 1098-2396|69|4|183-189

ISSN： 0887-4476

Source： SYNAPSE (ELECTRONIC), Vol.69, Iss.4, 2015-04, pp. : 183-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Signaling via Dopamine D1 and D3 Receptors Oppositely Regulates Cocaine-Induced Structural Remodeling of Dendrites and Spines

Neurosignals, Vol. 20, Iss. 1, 2011-11 ,pp. : 15-34

Karger

Access to resources Recommend Favorite

Targeting cyclin D3/CDK6 activity for treatment of Parkinson's disease

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 133, Iss. 6, 2015-06 ,pp. : 886-897

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia

By Oda Yasunori Kanahara Nobuhisa Iyo Masaomi

International Journal of Molecular Sciences, Vol. 16, Iss. 12, 2015-12 ,pp. : 30144-30163

MDPI

Access to resources Recommend Favorite

Dopamine Mobilizes Mesenchymal Progenitor Cells Through D2‐Class Receptors and Their PI3K/AKT Pathway

STEM CELLS, Vol. 32, Iss. 9, 2014-09 ,pp. : 2529-2538

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mutations in LRRK2 as a Cause of Parkinson’s Disease

Neurosignals, Vol. 16, Iss. 1, 2007-12 ,pp. : 99-105

Karger

Access to resources Recommend Favorite